Article ID Journal Published Year Pages File Type
5537565 Vaccine 2017 8 Pages PDF
Abstract
In conclusion, simplicity of manufacturing process and low costs of production, coupled with encouraging immunogenicity data, make GMMA an attractive strategy to further investigate for the development of a vaccine against iNTS.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , ,